Cargando…
Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
Pulmonary artery hypertension is a common cardiovascular complication in preterm infants with bronchopulmonary dysplasia which is associated with increased morbidity and mortality. Inhaled iloprost is used as a therapeutic option in pulmonary hypertension, especially in adults. There have been but a...
Autores principales: | Hwang, Seung-Kyung, O, Yung-Chul, Kim, Nam-Su, Park, Hyun-Kyung, Yum, Myung-Kul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771848/ https://www.ncbi.nlm.nih.gov/pubmed/19949642 http://dx.doi.org/10.4070/kcj.2009.39.8.343 |
Ejemplares similares
-
Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010) -
Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009) -
Review of inhaled iloprost for the control of pulmonary artery hypertension in children
por: Tissot, Cecile, et al.
Publicado: (2009) -
Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010) -
Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial
hypertension
por: Fernandes, Caio J.C.S., et al.
Publicado: (2021)